ClinicalTrials.govpublic full text
Safety, Pharmacodynamics, Pharmacokinetics, and Immunogenicity of Ascending Doses BCD-261 in Healthy Subjects
healthy, anti-tl1a, anti-tnf-like ligand 1a, ulcerative colitis, inflammatory bowel disease, crohn's disease, interventional, phase1
This document is indexed with metadata only — full text is not available in the archive for this record.
Open the official source ↗
Related documents
Record · ID 858771
Retrieved via
Conceptio — every document is proof-bundled with source, license, and retrieval metadata.